This study investigates the Breathe Well device to test whether it is superior to the existing treatment standard of the Varian Realtime Position Management (RPM) system in assisting patients with deep inspiration breath hold.
Recent studies have demonstrated an increased risks of cardiac disease in breast cancer radiotherapy patients. For patients diagnosed \<50 years old, the risks for cardiovascular diseases/events were increased by 24-82% comparing left and right breast radiotherapy. The deep inspiration breath hold (DIBH) technique addresses this problem by reducing the heart dose by up to half, thus potentially reducing the increased rate of major coronary events by 20%. Providing patients with visual feedback in addition to audio guidance has been demonstrated to improve the reproducibility of the DIBH technique by 95% and stability by 80%. Breathe Well is a new audiovisual feedback device that may increase the accuracy and workflow of implementing DIBH for breast cancer patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
45
Breathe Well is an audiovisual biofeedback device used to assist patients to regulate their breathing whilst undergoing radiation treatment.
Varian Real-time Position Management (RPM) system
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Accuracy of Breathe Well
The accuracy will be measured by comparing 'Breathe Well' and RPM measurements with images acquired of the breast during the radiation treatment using an electronic portal imaging device (EPID).
Time frame: 2 years
Difference in set up times for Breathe Well vs RPM
The setup times for both systems, the 'Breathe Well' and the modified RPM system; will be measured for all fractions.
Time frame: 2 years
Patient comfort
To investigate patient comfort in using 'Breathe Well' via a patient survey.
Time frame: 2 years
Staff perception of Breathe Well
To investigate staff perception of 'Breathe Well' via a technology assessment survey.
Time frame: 2 years
To develop the use of EPID for real time MLC tracking during breast radiotherapy
Time frame: 2 years
To compare actual and planned doses
Using dose reconstruction estimate the dose distribution delivered during radiotherapy and compare this with the planned dose.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.